This inventor holds 3 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Revolution Medicines, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Julie Chu-Li Lee: Innovator in mTOR Inhibitors
Introduction
Julie Chu-Li Lee is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of mTOR inhibitors. With a total of 3 patents to her name, her work is paving the way for advancements in treating diseases mediated by mTOR.
Latest Patents
Among her latest patents, Julie has developed C26-linked rapamycin analogs as mTOR inhibitors. This patent focuses on compounds and compositions that inhibit mTOR, along with methods for treating diseases associated with mTOR. The innovative approaches outlined in her patents are crucial for advancing therapeutic options in this area.
Career Highlights
Julie currently works at Revolution Medicines, Inc., where she continues to push the boundaries of research in her field. Her expertise and dedication have positioned her as a key player in the development of new therapeutic strategies.
Collaborations
Throughout her career, Julie has collaborated with talented individuals such as Jennifer Pitzen and Micah James Evans Gliedt. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Julie Chu-Li Lee is a remarkable inventor whose work in mTOR inhibitors is making a significant impact in the medical field. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile